NetworkNewsBreaks – Cybin Inc. (NYSE American: C
Post# of 341
(Total Views: 205)
Posted On: 11/11/2021 3:28:40 PM
NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Jefferies London Healthcare Conference
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to be held in a virtual format from Nov. 18-19, 2021. Drysdale’s presentation will be available on demand beginning at 8:00 a.m. GMT on Thursday, Nov. 18 through 5:00 p.m. GMT on Friday, Nov. 19. Interested parties should visit https://nnw.fm/0E9bJ to register for the webcast and view the presentation. An archived webcast will be available on the company’s investor relations website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to be held in a virtual format from Nov. 18-19, 2021. Drysdale’s presentation will be available on demand beginning at 8:00 a.m. GMT on Thursday, Nov. 18 through 5:00 p.m. GMT on Friday, Nov. 19. Interested parties should visit https://nnw.fm/0E9bJ to register for the webcast and view the presentation. An archived webcast will be available on the company’s investor relations website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Cybin Inc (CYBN) Stock Research Links
Scroll down for more posts ▼